Go to the list of all blogs
Sergey Savastiouk's Avatar
published in Blogs
Nov 15, 2026
TickeronGET DAILY SIGNALS
AHR vs CTRE: Weighing Two Healthcare REITs With Different Growth Paths

AHR vs CTRE: Weighing Two Healthcare REITs With Different Growth Paths

Key Takeaways

  • Tickeron AI Verdict: AHR — American Healthcare REIT's more consistent trend, stronger relative performance, and robust analyst consensus give it the edge over CareTrust REIT in the current environment.
  • AHR has posted 11 consecutive quarters of double-digit same-store net operating income (NOI) growth, while CTRE is accelerating its earnings but has seen its share price pull back in recent weeks.
  • Both companies are healthcare real estate investment trusts (REITs), but they differ sharply: AHR leans into operated senior housing, while CTRE is anchored in triple-net leased skilled nursing with a new U.K. expansion.
  • Relative performance diverged — AHR has outperformed the broader market this year, whereas CTRE has lagged despite repeated guidance increases.
  • For the latest coverage, explore AHR Major News and AHR Today's Price Move, as well as CTRE Major News and CTRE Today's Price Move.
  • To see how automated strategies are navigating this market, visit the Trending AI Robots page.

Setting the Stage for the Comparison

Both AHR and CTRE operate in the healthcare real estate sector, yet they pursue meaningfully different growth models. This stock comparison is relevant for investors evaluating how two fast-growing healthcare REITs are positioned amid shifting interest rates, an aging population, and active acquisition pipelines. One is a senior-housing operator capturing upside directly, while the other is a net-lease landlord diversifying internationally. Understanding their relative performance, capital structures, and momentum helps traders and longer-term investors weigh market positioning — and assess which name currently presents the stronger risk-adjusted setup. I also checked this using Tickeron’s AI Screener to see how the stocks compare to others in the industry.

AHR Overview and Recent Performance

American Healthcare REIT (AHR) owns and operates a diversified healthcare portfolio spanning senior housing operating properties (SHOP), integrated senior health campuses under its Trilogy platform, outpatient medical buildings, and triple-net leased assets. Its operating model is the centerpiece of the story, allowing the company to capture revenue and margin upside directly rather than relying solely on fixed rents.

Recent market activity has been notably supportive. The company reported third-quarter normalized funds from operations (NFFO) of $0.58 per share, beating consensus, and extended its streak of double-digit same-store NOI growth to 11 straight quarters. SHOP same-store NOI growth accelerated to 28.2%, while total portfolio NOI grew 13.8%. Management raised full-year NFFO guidance to a range of $2.23–$2.26, its third increase of the year, and reduced net debt-to-EBITDA to about 1.9x. The shares have outperformed the broader market this year, and analyst consensus remains a "Strong Buy" with an average price target well above recent trading levels. That said, meaningful share issuance to fund roughly $2 billion in completed investments introduces some dilution that investors are weighing against accelerating per-share growth. From what I see, the consistent organic growth here stands out.

CTRE Overview and Recent Performance

CareTrust REIT (CTRE) is a self-administered REIT that owns, acquires, and leases skilled nursing, seniors housing, and other healthcare properties, primarily through long-term triple-net leases. It has historically maintained low leverage and a strong balance sheet, which has supported an aggressive acquisition program.

Fundamentally, the company has delivered accelerating results. Third-quarter normalized FFO reached $0.54 per share, up 20% year over year, and management raised full-year guidance for the fourth time. Year-to-date investments have climbed to roughly $2.9 billion, headlined by a partnership to acquire 45 newly built U.K. care homes. Despite this, the stock has experienced a notable pullback in recent weeks, trading below its 200-day moving average as investors weighed lower blended deal yields, rising leverage, and a series of equity offerings — including a roughly $637.5 million common stock offering priced this month. The dividend yield near 4% and a "Buy" consensus provide a measure of support, but near-term sentiment has cooled relative to the company's operating momentum.

Head-to-Head Comparison

The clearest contrast between the two names lies in their business models. AHR derives much of its growth from operating senior housing, capturing margin expansion directly as occupancy and pricing improve. CTRE, by comparison, is predominantly a triple-net landlord whose tenants bear operating risk, while the company expands its asset base through acquisitions and a new U.K. foothold.

Growth drivers also differ. AHR's momentum is anchored in same-store NOI acceleration and disciplined pricing, with an acquisition pipeline exceeding $1 billion. CTRE's growth is more external, driven by a record investment pace, though blended yields have edged lower and leverage has crept upward. On market sentiment, AHR has enjoyed favorable price action and estimate revisions, while CTRE faces a disconnect between strong earnings and negative price reaction tied to dilution concerns. Risk factors for AHR include operator execution and share issuance; for CTRE, they center on integration of the U.K. platform and financing-related overhang. One thing that stands out is how these differences shape near-term positioning.

Tickeron AI Verdict

Based on observable trend consistency, relative strength, and market positioning, Tickeron's AI would currently favor AHR. The stock has sustained a steadier uptrend, delivered repeated upward guidance revisions supported by organic same-store growth, and maintained a stronger analyst consensus with meaningful upside to average price targets. While CTRE shows impressive fundamental acceleration, its recent price action and financing-related sentiment shift suggest less favorable short-term positioning. These conditions give AHR a probabilistic edge at present, though the balance could shift as either company's catalysts and capital markets evolve.

Exploring AI Tools for Market Context

In my analysis of these two REITs, I turned to Tickeron’s AI Daily Buy/Sell Signals to cross-check momentum signals across the sector. It offers a quick way to see how automated models are interpreting recent price and volume data alongside the fundamental trends we’ve discussed. This step helped confirm the relative strength I was observing without adding extra layers of complexity to the review.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: CTRE, AHR

Contributor

Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.


CTRE in upward trend: 10-day moving average broke above 50-day moving average on November 10, 2026

The 10-day moving average for CTRE crossed bullishly above the 50-day moving average on November 10, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 11 of 15 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 73%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on November 02, 2026. You may want to consider a long position or call options on CTRE as a result. In 48 of 80 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 60%.

CTRE moved above its 50-day moving average on November 04, 2026 date and that indicates a change from a downward trend to an upward trend.

Following a +4.52% 3-day Advance, the price is estimated to grow further. Considering data from situations where CTRE advanced for three days, in 217 of 324 cases, the price rose further within the following month. The odds of a continued upward trend are 67%.

Bearish Trend Analysis

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 26 of 64 cases where CTRE's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 41%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where CTRE declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 49%.

CTRE broke above its upper Bollinger Band on November 06, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Aroon Indicator for CTRE entered a downward trend on October 19, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Profit vs. Risk Rating rating for this company is 9 (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 60, placing this stock better than average.

The Tickeron Price Growth Rating for this company is 55 (best 1 - 100 worst), indicating fairly steady price growth. CTRE’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is 61 (best 1 - 100 worst), pointing to average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is 74 (best 1 - 100 worst), indicating slightly better than average sales and a considerably profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Valuation Rating of 97 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.010) is normal, around the industry mean (3.134). P/E Ratio (23.881) is within average values for comparable stocks, (30.791). Projected Growth (PEG Ratio) (0.370) is also within normal values, averaging (1.649). Dividend Yield (0.041) settles around the average of (0.050) among similar stocks. CTRE's P/S Ratio (18.762) is very high in comparison to the industry average of (6.013).

Industry description

The industry includes companies that publish and market books and magazines/periodicals. John Wiley & Sons, Inc., Meredith Corporation and Scholastic Corporation are some of the biggest companies in this industry. Like many other industries, publishing companies have branched out into online/digital publications (while retaining their original print business), to capture the burgeoning market in electronic media. Business could be cyclical in certain cases, since weak consumer sentiment during an economic downturn might depress sales of some magazines and books.

Market Cap

The average market capitalization across the Publishing: Books/Magazines Industry is 17.39B. The market cap for tickers in the group ranges from 113.09K to 176.55B. WELL holds the highest valuation in this group at 176.55B. The lowest valued company is DIGI at 113.09K.

High and low price notable news

The average weekly price growth across all stocks in the Publishing: Books/Magazines Industry was -4%. For the same Industry, the average monthly price growth was -2%, and the average quarterly price growth was -6%. NHPBP experienced the highest price growth at 0%, while MPT experienced the biggest fall at -13%.

Volume

The average weekly volume growth across all stocks in the Publishing: Books/Magazines Industry was 0%. For the same stocks of the Industry, the average monthly volume growth was 27% and the average quarterly volume growth was 32%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 66
P/E Growth Rating: 60
Price Growth Rating: 53
SMR Rating: 77
Profit Risk Rating: 59
Seasonality Score: -8 (-100 ... +100)
Trend Prediction Engine 4
View a ticker or compare two or three
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a real estate investment trust

Industry PublishingBooksMagazines

Industry
Real Estate Investment Trusts
Address
24901 Dana Point Harbor Dr
Phone
+1 949 542-3130
Employees
43
Web
https://www.caretrustreit.com
Interact to see
Advertisement
UNH dropped -7.80% to $359.29 from Tuesday's $389.68 close, extending a two-session decline to roughly -13% and touching its lowest level in about seven weeks; the move occurred during regular market hours. The selloff accelerated on the CMS "CRUSH" proposal unveiled Nov. 16, which would extrapolate Medicare Advantage risk-adjustment audit findings from samples across entire contracts back to payment year 2018 and drop the fee-for-service adjuster; CMS estimates roughly $9 billion in industry clawbacks per payment year, and UnitedHealth, the largest MA insurer, has not sized its exposure.
SAP's U.S. shares fell from Monday's close of $233.83 to $221.99 by late Tuesday morning in New York, a -5.06% decline recorded during regular trading hours. The company-specific trigger was the announced exit of Chief Customer Officer Thomas Saueressig, an executive board member since 2019, who will leave at the end of March 2027 to become CEO of IONOS; the disclosure came before the U.S. open.
Different growth engines: MRVL is riding accelerating AI data-center demand for custom chips and networking, while QCOM remains heavily tied to a soft smartphone market. Momentum contrast: Marvell's data-center revenue guidance has strengthened, whereas Qualcomm's near-term outlook has been pressured by memory-supply constraints and shrinking handset volumes.
TMC fell from Monday's $2.11 close to $1.96 by 10:10 a.m. ET, a -7.11% decline that occurred entirely in the regular session after an early premarket gain faded. No verified news or fundamental catalyst found for the drop; the move is likely technical, extending the post-Q3 unwind that followed NOAA pushing its certification decision to mid-December, with the stock averaging a 4.0% daily swing and logging 11 sessions of 7%-or-larger moves in the last 60.
IonQ slid from Monday's close of $26.45 to $24.73 on Tuesday, a -6.50% move that unfolded during regular trading hours after modest premarket gains faded. The decline was sector-driven rather than company-specific: quantum and AI-adjacent speculative names extended a multi-session liquidation ahead of Nvidia's quarterly report, with unease over Nvidia's abrupt CEO transition keeping risk appetite weak.